67
Views
3
CrossRef citations to date
0
Altmetric
Articles

Dielectric barrier discharge induced the degradation of the emerging contaminant ibuprofen in aqueous solutions

, , &
Pages 4469-4475 | Received 19 Jun 2012, Accepted 01 May 2013, Published online: 25 Jun 2013
 

Abstract

This study focused on the degradation of the worldwide nonsteroidal anti-inflammatory drug (NSAID) ibuprofen (IBP) by dielectric barrier discharge (DBD). Factors affecting IBP degradation efficiency were examined, such as output power, initial ibuprorfen concentration, solution pH values, and various additives (H2O2, t-BuOH, humic acid). When IBP concentration of 18 mg/L and the output power of 70 W were chosen, 95.6% of IBP was removed after 5 min treatment. Humic acid and 0.3% H2O2 additives enhanced the IBP degradation process, while 1% H2O2 additive restrained the degradation process of IBP. The addition of t-BuOH also hindered the degradation process of IBP. The degradation of IBP was found to be affected by solution pH, with higher degradation efficiency occurring under strong acidic condition than alkaline and neutral conditions. The solution pH values became lower with the increasing of discharge time. High-performance liquid chromatography (HPLC) and electrospray ionization mass spectrometry (ESMS) techniques were employed to identify the IBP derivatives. The mono-hydroxylates of IBP, and the products due to the oxidation of propanoic acid, and isobutyl substituents of IBP were identified.

Acknowledgment

This work has been supported jointly by the National Natural Science Foundation (Grant No. 11075039).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.